NASDAQ: EVO
Evotec Se Stock Ownership - Who owns Evotec Se?

Insider buying vs selling

Have Evotec Se insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EVO insiders and whales buy or sell their stock.

EVO Shareholders

What type of owners hold Evotec Se stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Mubadala Investment Co Pjsc2.59%4,597,701$19.17MInstitution
Wellington Management Group LLP1.07%1,903,401$7.94MInstitution
Blackrock Inc0.86%1,522,664$6.35MInstitution
Dcf Advisers LLC0.42%751,579$3.13MInstitution
Morgan Stanley0.05%88,041$367.13kInstitution
Abc Arbitrage Sa0.04%77,919$324.92kInstitution
Tower Research Capital LLC Trc0.02%41,185$171.74kInstitution
Lighthouse Investment Partners LLC0.02%37,545$156.56kInstitution
Fore Capital LLC0.01%17,005$70.91kInstitution
Ubs Group Ag0.01%13,620$56.80kInstitution

1 of 3

EVO vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EVO5.12%0.00%
ANIP29.20%70.80%Net SellingNet Selling
HROW28.43%71.57%Net SellingNet Selling
DVAX65.36%34.64%Net Selling
PAHC44.43%55.57%Net Buying

Evotec Se Stock Ownership FAQ

Who owns Evotec Se?

Evotec Se (NASDAQ: EVO) is owned by 5.12% institutional shareholders, 0.00% Evotec Se insiders, and 94.88% retail investors. Mubadala Investment Co Pjsc is the largest individual Evotec Se shareholder, owning 4.60M shares representing 2.59% of the company. Mubadala Investment Co Pjsc's Evotec Se shares are currently valued at $18.71M.

If you're new to stock investing, here's how to buy Evotec Se stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.